RO132299A3 - Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active () - Google Patents

Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Info

Publication number
RO132299A3
RO132299A3 ROA201700340A RO201700340A RO132299A3 RO 132299 A3 RO132299 A3 RO 132299A3 RO A201700340 A ROA201700340 A RO A201700340A RO 201700340 A RO201700340 A RO 201700340A RO 132299 A3 RO132299 A3 RO 132299A3
Authority
RO
Romania
Prior art keywords
immunologically active
active proteins
immunogen
preparing
egg
Prior art date
Application number
ROA201700340A
Other languages
English (en)
Other versions
RO132299A0 (ro
Inventor
Ionel Victor Pătraşcu
Original Assignee
Fântână Raul Sorin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fântână Raul Sorin filed Critical Fântână Raul Sorin
Priority to ROA201700340A priority Critical patent/RO132299A3/ro
Publication of RO132299A0 publication Critical patent/RO132299A0/ro
Priority to EP18814708.6A priority patent/EP3651793A1/en
Priority to CN201880050871.0A priority patent/CN111263639A/zh
Priority to US16/620,100 priority patent/US11458196B2/en
Priority to PCT/RO2018/000008 priority patent/WO2019039948A1/en
Publication of RO132299A3 publication Critical patent/RO132299A3/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0002Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Invenţia se referă la un procedeu de obţinere a unui biopreparat imunologic, utilizat în tratamentul deficienţelor imune şi infecţiilor cu germeni sensibili sau rezistenţi la antibiotice. Procedeul conform invenţiei constă în imunizarea unor găini ouătoare din rasa Leghorn sau Rhode Island Red, de 18...20 săptămâni, cu un imunogen complex, format din 18...24 antigene preparate din bacterii, levuri, ciuperci, virusuri, paraziţi, inactivate cu formol şi binar etilenimină în amestec cu glutamat de sodiu, ca imunomodulator, un marker biologic şi un adjuvant imunologic uzual, imunogenul fiind structurat în trei variante: un imunogen standard, format din 1...24 antigene, un imunogen specific, format într-un suport imun, realizat după imunizarea cu 20 de microbi, şi reimunizat cu un antigen monospecific, format din şapte tulpini bacteriene ale aceleiaşi specii, şi un imunogen personalizat, format din antigene preparate dintr-un produs patogen prelevat de la un pacient, sau din 20...26 tulpini microbiene frecvent izolate de la pacienţi, inocularea fiind realizată parenteral, cu câte 2 ml din fiecare variantă, la un interval de 30 şi, respectiv, 44 de zile de la prima inoculare, după care se recoltează ouăle care conţin minimum 300 mg/ou proteine imunologic active (PIA), şi din care se foloseşte gălbenuşul pentru IgY, albuşul pentru PIA, membrana cochilieră pentru PIA şi imunomodulatori, rezultând preparate care se condiţionează uzual, în vederea utilizării preventive şi curative.
ROA201700340A 2017-06-06 2017-06-06 Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active () RO132299A3 (ro)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ROA201700340A RO132299A3 (ro) 2017-06-06 2017-06-06 Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()
EP18814708.6A EP3651793A1 (en) 2017-06-06 2018-06-05 Composition, preparation method and evaluation of a complex immunogen named i-spga for production of immunological active proteins (iap)
CN201880050871.0A CN111263639A (zh) 2017-06-06 2018-06-05 用于免疫活性蛋白(iap)生产的名为i-spga的复合免疫原的组分、制备方法和评估
US16/620,100 US11458196B2 (en) 2017-06-06 2018-06-05 Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP)
PCT/RO2018/000008 WO2019039948A1 (en) 2017-06-06 2018-06-05 COMPOSITION, PROCESS FOR THE PREPARATION AND EVALUATION OF A COMPLEX IMMUNOGEN CALLED I-SPGA FOR THE PRODUCTION OF IMMUNOLOGICALLY ACTIVE PROTEINS (IAP)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ROA201700340A RO132299A3 (ro) 2017-06-06 2017-06-06 Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Publications (2)

Publication Number Publication Date
RO132299A0 RO132299A0 (ro) 2017-12-29
RO132299A3 true RO132299A3 (ro) 2018-12-28

Family

ID=60688726

Family Applications (1)

Application Number Title Priority Date Filing Date
ROA201700340A RO132299A3 (ro) 2017-06-06 2017-06-06 Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Country Status (5)

Country Link
US (1) US11458196B2 (ro)
EP (1) EP3651793A1 (ro)
CN (1) CN111263639A (ro)
RO (1) RO132299A3 (ro)
WO (1) WO2019039948A1 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO132299A3 (ro) * 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO56778A2 (ro) 1971-12-31 1974-08-01
RO75101A2 (ro) 1979-03-22 1980-09-30 Laboratorul De Virusuri Aviare,Ro Vaccin inactivat contra leucozei enzootice bovine si ovine si procedeu de preparare a lui
RO80570B1 (ro) 1982-04-22 1984-09-30 Victor Ionel Patrascu Procedeu de preparare a vaccinului contra bolii lui marek
US5853765A (en) 1982-06-03 1998-12-29 Dcv, Inc. Anti-cholesterolemic egg, vaccine and method for production, and use
SE9100556D0 (sv) 1991-02-26 1991-02-26 Holmgren Jan Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
DE69632235T2 (de) 1995-10-18 2004-08-26 Akzo Nobel N.V. Newcastle-Krankheitsvirus-Kombinationsimpfstoff
US20060029617A1 (en) 1997-10-03 2006-02-09 Charreyre Catherine E Porcine circovirus and Helicobacter combination vaccines and methods of use
US20040005327A1 (en) 2002-05-16 2004-01-08 Subramanian Iyer Immune T-cell stimulation
JP4873632B2 (ja) * 2004-01-21 2012-02-08 メリアル リミテッド 改良された不活化fcvワクチン
WO2007124755A1 (en) * 2006-05-02 2007-11-08 The Antibody Project Aps Method for immunizing an avian species
EP2183281A1 (en) * 2007-08-30 2010-05-12 Ågerup, Bengt LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
US8679504B2 (en) * 2008-05-22 2014-03-25 University Of Georgia Research Foundation Inc. Poultry viral materials and methods related thereto
WO2011044158A1 (en) 2009-10-09 2011-04-14 New York Blood Center, Inc. Immunopotentiator-linked oligomeric influenza immunogenic compositions
WO2014134439A1 (en) 2013-03-01 2014-09-04 New York Blood Center, Inc. Immunogenic composition for mers coronavirus infection
RO130063A8 (ro) * 2014-08-28 2017-06-30 Romvac Company S.A. Producerea şi utilizarea ovotransferinei moderne ()
RO130213A8 (ro) 2014-10-29 2017-06-30 Romvac Company S.A. Producerea şi folosirea oului hiperimun - pc2
CN105518377B (zh) 2014-10-31 2018-10-26 深圳市大疆创新科技有限公司 一种气体泄漏的处理方法、装置及飞行器
RO130418A8 (ro) * 2015-01-13 2017-06-30 Romvac Company S.A. Producerea şi utilizarea ovotransferinei pc2 ()
CN104892756A (zh) * 2015-06-18 2015-09-09 成都安蒂康生物科技有限公司 一种抗菌鸡卵黄复合抗体及其制备方法与应用
RO130852A8 (ro) * 2015-09-03 2017-06-30 Romvac Company S.A. Producerea şi utilizarea oului hiperimun personalizat () în tratamentul de urgenţă al pacienţilor infectaţi cu germeni patogeni
RO130965A8 (ro) 2015-10-16 2017-06-30 Romvac Company S.A. Producerea şi utilizarea oului hiperimun personalizat () în tratamentul psoriazisului
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Also Published As

Publication number Publication date
CN111263639A (zh) 2020-06-09
RO132299A0 (ro) 2017-12-29
US20210121552A1 (en) 2021-04-29
WO2019039948A1 (en) 2019-02-28
EP3651793A1 (en) 2020-05-20
US11458196B2 (en) 2022-10-04

Similar Documents

Publication Publication Date Title
KR102049976B1 (ko) 새우 조기 폐사 증후군 및 흰반점 바이러스에 대한 항체 및 이의 응용
RU2429012C1 (ru) Способ изготовления ассоциированной вакцины против колибактериоза, стрептококкоза и энтерококковой инфекции телят и поросят
RO132299A3 (ro) Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()
JP5598820B2 (ja) 魚類のスクーチカ症予防治療ワクチン
KR101715625B1 (ko) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
CZ282089B6 (cs) Způsob výroby očkovacích látek
RU2432174C1 (ru) Способ получения эшерихиозного анатоксина
US2787576A (en) Attenuating b. abortus and p. multocida
RU2538158C1 (ru) Способ изготовления вакцины, ассоциированной против эшерихиоза, стрептококкоза и стафилококкоза крупного рогатого скота
KR100364198B1 (ko) 헬리코박터 파이로리에 대한 개선된 lgY 생성의유도방법 및 이에 의해 제조된 계란
Esmailnejad et al. Storage stability of anti-Salmonella typhimurium immunoglobulin Y in immunized quail eggs stored at 4◦ C
CN112625126A (zh) 抗蜂房哈夫尼菌卵黄抗体及其制备方法和应用
RU2650628C1 (ru) Способ получения вакцины ассоциированной против колибактериоза, стрептококкоза и энтерококковой инфекции телят и поросят
RU2761379C1 (ru) Поливалентная инактивированная вакцина против стрептококкозов свиней, способ ее получения и применения
RU2723711C1 (ru) Способ получения вакцины гидроокисьалюминиевой против мастита коров стрептококковой этиологии
RU2521651C1 (ru) ШТАММ БАКТЕРИЙ, Moraxella bovoculi "СХ-Ч6 N-ДЕП" ИСПОЛЬЗУЕМЫЙ ДЛЯ ИЗГОТОВЛЕНИЯ ДИАГНОСТИКУМОВ И ВАКЦИН ПРОТИВ ИНФЕКЦИОННОГО КЕРАТОКОНЪЮКТИВИТА КРУПНОГО РОГАТОГО СКОТА
RU2553555C1 (ru) ШТАММ БАКТЕРИЙ Pseudomonas aeruginosa ДЛЯ ИЗГОТОВЛЕНИЯ ВАКЦИНЫ ПРОТИВ ПСЕВДОМОНОЗА СВИНЕЙ
KR20020068937A (ko) 항 대장균, 살모넬라 엔테라이티디스, 살모넬라티피뮤리움 및 헬리코박터 피로리의 특수면역단백질을공유한 계란 생산방법 및 상기 생산방법으로 생산된 계란,난황 및 상기 항-혼합균 특수면역단백질을 함유한요구르트 및 아이스크림
RU2301682C1 (ru) Вакцина для специфической профилактики хламидиоза крупного и мелкого рогатого скота
RU2098127C1 (ru) Ассоциированная вакцина "нековак" против некробактериоза крупного рогатого скота
RU2264227C1 (ru) Ассоциированная вакцина для специфической профилактики инфекционного кератоконъюнктивита крупного рогатого скота на основе антигенов бактерий moraxella bovis и герпесвируса типа i
RU2553631C1 (ru) ШТАММ БАКТЕРИИ Pseudomonas aeruginosa № 9 ДЛЯ ИЗГОТОВЛЕНИЯ ВАКЦИНЫ ПРОТИВ ПСЕВДОМОНОЗА СВИНЕЙ
NO852968L (no) Vaksine og fremstilling derav
RU2264458C1 (ru) Штамм n101 вниизж rotavirus крупного рогатого скота для изготовления диагностических, вакцинных и лечебных препаратов
RU2553553C1 (ru) ШТАММ БАКТЕРИЙ Pseudomonas aeruginosa ДЛЯ ИЗГОТОВЛЕНИЯ ВАКЦИНЫ ПРОТИВ ПСЕВДОМОНОЗА СВИНЕЙ